Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised, controlled, open-label, platform trial
Date
2022-02-18
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Citation
RECOVERY Collaborative Group 2022, 'Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised, controlled, open-label, platform trial', The Lancet, vol. 399, no. 10325, pp. 665-676. https://doi.org/10.1016/S0140-6736(22)00163-5